Tivic Health Systems, a San Francisco, CA-based bioelectronic medical device company that treats chronic conditions, raised $8m in seed funding.
Backers included Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, a physician network and individual investors.
The company, which has raised funds in a series of tranches, the most recent of which closed last week, intends to use the capital for marketing of the first product, ClearUP® Sinus Pain Relief.
Founded in 2016 and led by Jennifer Ernst, CEO, Tivic Health Systems is a bioelectronic device company dedicated to developing microcurrent therapy solutions for chronic diseases and conditions.
ClearUP – available in mid-September without a prescription and priced at $149 – is a clinically proven, FDA cleared bioelectronic solution that provides consumers with a drug free option to treat allergy-related sinus pain using microcurrent (low-level electrical stimulation). The proprietary technology delivers microcurrent waveforms that stimulate the nerves under the skin of the cheek, nose and eyebrow bone.